Saunders N B, Zollinger W D, Rao V B
Department of Biology, Catholic University of America, Washington, DC 20064.
Gene. 1993 Dec 31;137(2):153-62. doi: 10.1016/0378-1119(93)90001-j.
The predicted amino acid sequence was determined for the class-1 outer membrane protein, PorA, from a B:15:P1.7,3 strain of Neisseria meningitidis that is currently causing an epidemic of meningitis in Northern Chile. The P1.7,3 PorA showed a unique sequence in the exposed loop 4 of the putative porin structure that is different from all the reported PorA sequences. Based on the nucleotide (nt) sequence of the P1.7,3 porA, we designed two sets of PCR (polymerase chain reaction) primers that specifically amplified porA from any N. meningitidis strain, and a third set of primers that amplified porA only from the P1.7,3 strain. Using these primers, we developed a sensitive double hot-start nested PCR (HNPCR) strategy that could amplify porA and generate nt sequence from as low as a single colony-forming unit. This strategy consisted of three phases of PCR. The first two phases were designed to generate amplified target DNA that could be directly visualized by ethidium bromide staining starting from one to two molecules of Neisseria genome. The third phase was designed to generate a sequence of several hundred nt directly from the amplified DNA. A number of culture-negative cerebrospinal fluid samples from individuals suspected of meningitis during a vaccine trial were analyzed by this strategy to obtain more accurate information on the actual number of cases that occurred in the study and the non-study populations. The basic HNPCR strategy described here could be applied to amplify and sequence target DNAs from any low-copy-number biological sample.
已确定来自脑膜炎奈瑟菌B:15:P1.7,3菌株的1类外膜蛋白PorA的预测氨基酸序列,该菌株目前正在智利北部引发脑膜炎疫情。P1.7,3 PorA在假定孔蛋白结构的暴露环4中显示出独特序列,与所有已报道的PorA序列不同。基于P1.7,3 porA的核苷酸(nt)序列,我们设计了两组PCR(聚合酶链反应)引物,可从任何脑膜炎奈瑟菌菌株中特异性扩增porA,以及第三组仅从P1.7,3菌株中扩增porA的引物。使用这些引物,我们开发了一种灵敏的双热启动巢式PCR(HNPCR)策略,该策略可从低至单个菌落形成单位扩增porA并生成nt序列。该策略包括三个PCR阶段。前两个阶段旨在生成扩增的目标DNA,从一到两个脑膜炎奈瑟菌基因组分子开始,可通过溴化乙锭染色直接观察到。第三阶段旨在直接从扩增的DNA生成数百个nt的序列。通过该策略分析了疫苗试验期间疑似脑膜炎患者的一些培养阴性脑脊液样本,以获取关于研究人群和非研究人群中实际发病数的更准确信息。本文所述的基本HNPCR策略可用于扩增和测序任何低拷贝数生物样本中的目标DNA。